Pasithea Therapeutics Corp. Warrants (KTTAW) Live Share Price, Invest From India

Pasithea Therapeutics Corp. Warrants Stock Performance

as on July 14, 2026 at 2:15 pm IST

$0.01
Day's Price Range
$0.01
$0.01
52 Week's Low
52 Week's High
52-Week Price Range
$0.01
100.00%
Downside
-100.00%
Upside

Pasithea Therapeutics Corp. Warrants share price movements today

Previous Close: $0.01
Open: $0.01
Volume: 29.1K
Day's Low - High: $0.01 - $0.01

Pasithea Therapeutics Corp. Warrants Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Pasithea Therapeutics Corp. Warrants Stock Fundamentals & Key Indicators

Check Pasithea Therapeutics Corp. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-58.22%

Pasithea Therapeutics Corp. Warrants stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Pasithea Therapeutics Corp. Warrants with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Pasithea Therapeutics Corp. Warrants	NA	$-	NA	NA	0.00%	NA

Pasithea Therapeutics Corp. Warrants Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-4	-3	-3	-3	-3	-3	-3	-10	-4
EBITDA	-4	-3	-3	-2	-3	-3	-3	-2	-10	-4
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-3	-3	-2	-3	-3	-3	-3	-10	-2
Income Tax Expense	0	0	0	-	0	-	-	-	-	-
Net Income	-5	-3	-3	-2	-3	-3	-3	-3	-10	-2
Net Profit Margin	-517.07%	0.00%	0.00%	0.00%	-489.60%	0.00%	0.00%	0.00%	0.00%	0.00%

Pasithea Therapeutics Corp. Warrants Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	-	-
Gross Profit	0	0	0	0	0
Operating Income	-4	-12	-15	-14	-20
EBITDA	-4	-11	-15	-13	-20
Interest Expense	0	0	-	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-2	-11	-15	-13	-20
Income Tax Expense	0	0	453	-	-
Net Income	-2	-13	-15	-13	-20
Net Profit Margin	-14430.49%	-2864.29%	-3280.52%	0.00%	0.00%

Pasithea Therapeutics Corp. Warrants Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-3	-2	-3	-3	-3	-3	-2,838	-2
Operating Cash Flow	-4	-4	-3	-2	-3	-3	-2	-5	-4
Investing Cash Flow	-	-	-	-	-	-	-	0	-
Financing Cash Flow	-	-	4	0	1	5	0	56	0
Change in Cash	-4	-4	1	-2	-1	1	-2	51	-4

Pasithea Therapeutics Corp. Warrants Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-11	-15	-13	-20,427
Operating Cash Flow	-3	-13	-13	-13	-15,211
Investing Cash Flow	0	-2	0	-	11
Financing Cash Flow	55	-3	-3	4	63,518
Change in Cash	52	-19	-16	-9	48,337

About Pasithea Therapeutics Corp. Warrants

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumor; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Organisation	Pasithea Therapeutics Corp. Warrants
Headquarters	1111 Lincoln Road, Miami Beach, FL, United States, 33139
Industry	Health Care
CEO	Dr. Tiago Reis Marques M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Pasithea Therapeutics Corp. Warrants

Name	Title
Dr. Lawrence Steinman BA, M.D., Ph.D.	Co-Founder & Executive Chairman
Dr. Tiago Reis Marques M.D., Ph.D.	CEO & Director
Mr. Daniel H. Schneiderman	Chief Financial Officer
Dr. Kartik Krishnan M.D., Ph.D.	Chief Medical Officer

FAQs

What is Pasithea Therapeutics Corp. Warrants share price today?

Pasithea Therapeutics Corp. Warrants share price today is $0.01 as on July 14, 2026 at 8:45 am IST at the close of the market. Pasithea Therapeutics Corp. Warrants share today touched a day high of $0.01 and a low of $0.01.

What is the 52 week high and 52 week low for Pasithea Therapeutics Corp. Warrants share?

Pasithea Therapeutics Corp. Warrants share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Pasithea Therapeutics Corp. Warrants stock price today i.e. July 14, 2026 at 8:45 am IST is closed at $0.01,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Pasithea Therapeutics Corp. Warrants Stock (KTTAW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pasithea Therapeutics Corp. Warrants on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pasithea Therapeutics Corp. Warrants Shares that will get you 150.0000 shares as per Pasithea Therapeutics Corp. Warrants share price of $0.01 per share as on July 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy Pasithea Therapeutics Corp. Warrants Stock (KTTAW) from India?

Indian investors can start investing in Pasithea Therapeutics Corp. Warrants (KTTAW) shares with as little as ₹95.615 or $1 (as of July 14, 2026 at 4:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.15 in Pasithea Therapeutics Corp. Warrants stock (as per the Rupee-Dollar exchange rate as on July 14, 2026 at 4:41 pm IST). Based on Pasithea Therapeutics Corp. Warrants share’s latest price of $0.01 as on July 14, 2026 at 8:45 am IST, you will get 1000.0000 shares of Pasithea Therapeutics Corp. Warrants. Learn more about fractional shares .